LONG-TERM CYCLOSPORINE PHARMACOKINETIC CHANGES IN RENAL-TRANSPLANT RECIPIENTS - EFFECTS OF BINDING AND METABOLISM

被引：70
作者：
AWNI, WM
KASISKE, BL
HEIMDUTHOY, K
RAO, KV
机构：
[1] UNIV MINNESOTA,COLL PHARM,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 01期
关键词：
D O I：
10.1038/clpt.1989.7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：41 / 48
页数：8
相关论文
共 19 条
[1]   OPTIMIZED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF CYCLOSPORINE AND 3 OF ITS METABOLITES IN BLOOD AND URINE [J].
AWNI, WM ;
MALONEY, JA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 425 (01) :233-236
[2]  
AWNI WM, 1985, DRUG METAB DISPOS, V13, P127
[3]   CYCLOSPORINE NEPHROTOXICITY [J].
BENNETT, WM ;
PULLIAM, JP .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) :851-854
[4]   INVITRO IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE METABOLITES [J].
FREED, BM ;
ROSANO, TG ;
LEMPERT, N .
TRANSPLANTATION, 1987, 43 (01) :123-127
[5]   DEMOGRAPHIC-FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAY [J].
KAHAN, BD ;
KRAMER, WG ;
WIDEMAN, C ;
FLECHNER, SM ;
LORBER, MI ;
VANBUREN, CT .
TRANSPLANTATION, 1986, 41 (04) :459-464
[6]  
KAHAN BD, 1983, TRANSPLANT P, V15, P446
[7]   CYCLOSPORINE NEPHROTOXICITY - PATHOGENESIS, PROPHYLAXIS, THERAPY, AND PROGNOSIS [J].
KAHAN, BD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 8 (05) :323-331
[8]  
Maurer G, 1985, Transplant Proc, V17, P19
[9]  
MAURER G, 1984, DRUG METAB DISPOS, V12, P120
[10]   CYCLOSPORINE - 5 YEARS EXPERIENCE IN CADAVERIC RENAL-TRANSPLANTATION [J].
MERION, RM ;
WHITE, DJG ;
THIRU, S ;
EVANS, DB ;
CALNE, RY .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) :148-154
12